SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-22-020337
Filing Date
2022-11-15
Accepted
2022-11-15 09:24:46
Documents
2
Period of Report
2022-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 4178
2 POWER OF ATTORNEY poa.htm EX-24.1 4591
  Complete submission text file 0001567619-22-020337.txt   10449
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AYTU BIOPHARMA, INC. 373 INVERNESS PARKWAY, SUITE 206 ENGLEWOOD CO 80112
Business Address
BROOKE CHRISTOPHER (Reporting) CIK: 0001953013 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38247 | Film No.: 221389634